Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-016350
Filing Date
2025-06-03
Accepted
2025-06-03 12:58:04
Documents
1
Period of Report
2025-05-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 4585
  Complete submission text file 0001127602-25-016350.txt   6261
Mailing Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065
Business Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EMERSON ELECTRIC CO. 8000 W. FLORISSANT AVENUE ST. LOUIS MO 63136
Business Address
Karsanbhai Surendralal Lanca (Reporting) CIK: 0001754881 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-06571 | Film No.: 251018156